Difficulty: Medium
Average Score: 66%
Practice
An 83-year-old man is brought to the clinic by his family with complaints stating he can no longer perform his daily activities or be trusted to live on his own. During his neurological exam, he presents with moderate memory loss, apraxia, and anomia. Also, he displays aggressive behaviors throughout the physical exam. He was diagnosed to be in an early stage of Alzheimer's disease. What class of drugs would be most helpful in treating the patient?
Correct answer
B
Rationale
The correct answer is B) Cholinesterase inhibitors. In the case of Alzheimer's disease, cholinesterase inhibitors like donepezil, rivastigmine, and galantamine are commonly used to manage symptoms by increasing the levels of acetylcholine in the brain. Acetylcholine is a neurotransmitter that is depleted in Alzheimer's patients, leading to cognitive decline and memory loss. By inhibiting the enzyme that breaks down acetylcholine (cholinesterase), these drugs help improve cognitive function, behavior, and activities of daily living in patients with Alzheimer's disease.
Option A) Cholinesterase stimulants is incorrect because there is no such class of drugs. Cholinesterase inhibitors are the correct class used in Alzheimer's treatment.
Option C) Dopamine agonists are not indicated in the treatment of Alzheimer's disease. Dopamine is more associated with conditions like Parkinson's disease.
Option D) Muscarinic receptor inhibitors would worsen the symptoms in Alzheimer's disease as they would further decrease the already low levels of acetylcholine, exacerbating cognitive decline and behavioral symptoms.
In an educational context, understanding the rationale behind selecting the appropriate class of drugs for a specific condition is crucial for healthcare professionals. It highlights the importance of tailoring treatments to target the underlying pathophysiology of the disease. This case also emphasizes the significance of accurate diagnosis and appropriate pharmacological interventions in managing neurodegenerative disorders like Alzheimer's disease.
Option A) Cholinesterase stimulants is incorrect because there is no such class of drugs. Cholinesterase inhibitors are the correct class used in Alzheimer's treatment.
Option C) Dopamine agonists are not indicated in the treatment of Alzheimer's disease. Dopamine is more associated with conditions like Parkinson's disease.
Option D) Muscarinic receptor inhibitors would worsen the symptoms in Alzheimer's disease as they would further decrease the already low levels of acetylcholine, exacerbating cognitive decline and behavioral symptoms.
In an educational context, understanding the rationale behind selecting the appropriate class of drugs for a specific condition is crucial for healthcare professionals. It highlights the importance of tailoring treatments to target the underlying pathophysiology of the disease. This case also emphasizes the significance of accurate diagnosis and appropriate pharmacological interventions in managing neurodegenerative disorders like Alzheimer's disease.